CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
“Current technologies for the diagnosis of coronavirus are designed simply to detect the presence or lack of COVID-19 and therefore neglect to differentiate between this strain and other respiratory infections,” Peter FitzGerald, MD, managing director of Randox Laboratories, said in a press release. “We have therefore developed an extended Viral Respiratory Infection Array that tests simultaneously for COVID-19 and nine other viruses. This will eliminate the need for multiple back-and-forth tests before the root cause of symptoms is found and empower clinicians to make fast and informed decisions.”
The test is available on the Randox Evidence Investigator and has a turnaround time of five hours.
Pages: 1 2